Lung Cancer Biomarkers and Screening

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT00301119
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Accepted

Study Details

RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.

Key Dates

Start date
May 31, 2000
Status verified
May 2026
Primary completion
May 31, 2030
Completion
May 31, 2030

Study Design

Enrollment
3,606 participants (estimated)

Arms

  • Arm: lung cancer screening cohort
    observational only. no intervention. current, former and never smokers over age 50 without history of cancer, except for non melanoma skin cancer, no previous treatment with chemotherapy.
  • Arm: r/o lung cancer
    observational only. no intervention. patients with CT findings suspicious for lung cancer who are undergoing bronchoscopy and/or surgery.

Primary Outcome Measure

Lung cancer diagnosis as measured by CT scan findings and pathology findings annually [ Time Frame: 07/01/2015 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Cancer Institute at New York University Medical CenterNew YorkNew York10016
James J. Tsay, MD, MSc
[email protected]
212-598-6351

Find similar trials in New York, NY

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
NYU Cancer Institute at New York University Medical Center· New York, NY

Related Studies